Novartis launches legal challenge against PCT cluster
A pharmaceutical company is taking a primary care trust cluster to court over its decision to encourage the use of a cheaper, unlicensed drug in a case that could be worth millions to the NHS.
Continue reading this article – simply subscribe below
Subscribe now for instant access to hsj.co.uk and our mobile site. Choose the package that suits you and get the weekly magazine, iPad app or both.
If you are a Health Service Journal subscriber please sign in with your email address and click submit: